Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 10, 2011, Pages 2240-2247

  Shi, Dawei ^a   Li, Liang ^b   Zhao, Yuling ^c   Jia, Qiong ^a   Li, Hui ^c   Coulter, Christopher ^d   Jin, Qi ^a   Zhu, Guofeng ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c DEPARTMENT OF HEALTH   (Hong Kong)

^d ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

Author keywords

embB306; embB497; Ethambutol; Genetic background; MIRU VNTR

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; CODON; CONTROLLED STUDY; EMBB GENE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POLYMERASE CHAIN REACTION;

ANTITUBERCULAR AGENTS; BASE SEQUENCE; CHINA; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ETHAMBUTOL; GENETIC MARKERS; GENOTYPE; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PENTOSYLTRANSFERASES; RIFAMPIN; SEQUENCE ANALYSIS, DNA; STREPTOMYCIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 80052904114     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkr284     Document Type: Article

References (33)

1. WHO. Anti-Tuberculosis Drug Resistance in the World: Fourth Global Report. http://whqlibdoc.who.int/hq/2008/WHO_HTM_TB_2008.394_eng.pdf (22 April 2011, date last accessed).
2. He GX, Zhao YL, Jiang GL et al. Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect Dis 2008; 8: 166.
3. American Thoracic Society, CDC, Infectious Diseases Society of America. Treatment of tuberculosis. MMWR Recomm Rep 2003; 52: 1-77.
4. Alcaide F, Pfyffer GE, Telenti A. Role of embB in natural and acquired resistance to ethambutol in mycobacteria. Antimicrob Agents Chemother 1997; 41: 2270-3.
5. Safi H, Fleischmann RD, Peterson SN et al. Allelic exchange and mutant selection demonstrate that common clinical embCAB gene mutations only modestly increase resistance to ethambutol in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2010; 54: 103-8.
6. Safi H, Sayers B, Hazbon MH et al. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin. Antimicrob Agents Chemother 2008; 52: 2027-34.
7. Starks AM, Gumusboga A, Plikaytis BB et al. Mutations at embB codon 306 are an important molecular indicator of ethambutol resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2009; 53: 1061-6.
8. Ahmad S, Jaber AA, Mokaddas E. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait. Tuberculosis (Edinb) 2007; 87: 123-9.
9. Plinke C, Rusch-Gerdes S, Niemann S. Significance of mutations in embB codon 306 for prediction of ethambutol resistance in clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother 2006; 50: 1900-2.
10. Ramaswamy SV, Amin AG, Goksel S et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2000; 44: 326-36.
11. Sreevatsan S, Stockbauer KE, Pan X et al. Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother 1997; 41: 1677-81.
12. Hazbon MH, Bobadilla del Valle M, Guerrero MI et al. Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance. Antimicrob Agents Chemother 2005; 49: 3794-802.
13. Lee AS, Othman SN, Ho YM et al. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 2004; 48: 4447-9.
14. Mokrousov I, Otten T, Vyshnevskiy B et al. Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from northwestern Russia: implications for genotypic resistance testing. J Clin Microbiol 2002; 40: 3810-3.
15. Shen X, Shen GM, Wu J et al. Association between embB codon 306 mutations and drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2007; 51: 2618-20.
16. Perdigao J, Macedo R, Ribeiro A et al. Genetic characterisation of the ethambutol resistance-determining region in Mycobacterium tuberculosis: prevalence and significance of embB306 mutations. Int J Antimicrob Agents 2009; 33: 334-8.
17. Plinke C, Cox HS, Kalon S et al. Tuberculosis ethambutol resistance: concordance between phenotypic and genotypic test results. Tuberculosis (Edinb) 2009; 89: 448-52.
18. Borrell S, Gagneux S. Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis 2009; 13: 1456-66.
19. Cohen T, Sommers B, Murray M. The effect of drug resistance on the fitness of Mycobacterium tuberculosis. Lancet Infect Dis 2003; 3: 13-21.
20. Zaczek A, Brzostek A, Augustynowicz-Kopec E et al. Genetic evaluation of relationship between mutations in rpoB and resistance of Mycobacterium tuberculosis to rifampin. BMC Microbiol 2009; 9: 10.
21. Canetti G, Froman S, Grosset J et al. Mycobacteria: laboratory methods for testing drug sensitivity and resistance. Bull World Health Organ 1963; 29: 565-78.
22. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes: Approved Standard M24-A. NCCLS, Wayne, PA, USA, 2003.
23. Chen J, Tsolaki AG, Shen X et al. Deletion-targeted multiplex PCR (DTM-PCR) for identification of Beijing/W genotypes of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2007; 87: 446-9.
24. Luo T, Zhao M, Li X et al. Selection of mutations to detect MDR TB in Shanghai, China. Antimicrob Agents Chemother 2009; 54: 1075-81.
25. Zhang L, Chen J, Shen X et al. Highly polymorphic variable-number tandem repeats loci for differentiating Beijing genotype strains of Mycobacterium tuberculosis in Shanghai, China. FEMS Microbiol Lett 2008; 282: 22-31.
26. Allix-Beguec C, Harmsen D, Weniger T et al. Evaluation and strategy for use of MIRU-VNTRplus, a multifunctional database for online analysis of genotyping data and phylogenetic identification of Mycobacterium tuberculosis complex isolates. J Clin Microbiol 2008; 46: 2692-9.
27. Tamura K, Dudley J, Nei M et al. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-9.
28. van Soolingen D, Hermans PW, de Haas PE et al. Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis. J Clin Microbiol 1991; 29: 2578-86.
29. Plinke C, Cox HS, Zarkua N et al. embCAB sequence variation among ethambutol-resistant Mycobacterium tuberculosis isolates without embB306 mutation. J Antimicrob Chemother 2010; 65: 1359-67.
30. Johnson R, Jordaan AM, Pretorius L et al. Ethambutol resistance testing by mutation detection. Int J Tuberc Lung Dis 2006; 10: 68-73.
31. Ramaswamy SV, Dou SJ, Rendon A et al. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol 2004; 53: 107-13.
32. Parsons LM, Salfinger M, Clobridge A et al. Phenotypic and molecular characterization of Mycobacterium tuberculosis isolates resistant to both isoniazid and ethambutol. Antimicrob Agents Chemother 2005; 49: 2218-25.
33. Van Rie A, Warren R, Mshanga I et al. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J Clin Microbiol 2001; 39: 636-41.